[Use of an MAO inhibitor in the treatment of psoriasis vulgaris].
Thirteen patients suffering from psoriasis vulgaris of middle-high severity, were treated with tranylcypromine (5 mg once a day) or with placebo during a four months period, following a double-blind randomized trial. Results were evaluated with a statistical analysis of the data obtained with a PASI method. Tranylcypromine, an MAOI drug, appears to be effective in reducing the extension and severity of lesions.
Di Prima
T
T
De Pasquale
R
R
D000293:Adolescent; D000328:Adult; D002648:Child; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy* / Q000473:pathology; D016032:Randomized Controlled Trials as Topic; D014191:Tranylcypromine / Q000627:therapeutic use*
D014191:Tranylcypromine
Impiego di un IMAO nel trattamento della psoriasi volgare.